GlassScriptPhysician profile
Arnau Aparicio-Altuna
NPI 1154724508
$1,549.50
in general payments reported to CMS, 2019-2025
10 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.72 · 2020: $50.65 · 2021: $374 · 2022: $27.04 · 2023: $135 · 2024: $752 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $811 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $811.42 |
| Food and Beverage | $213.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $811.42 | 2023-2024 | Opalescence |
| Keystone Dental INC. | $201.51 | 2019-2021 | |
| Align Technology, INC. | $190.11 | 2021 | |
| Dental Health Products, INC. | $130.97 | 2024-2025 | |
| Straumann USA LLC | $123.28 | 2021-2025 | |
| Biolase, INC. | $37.65 | 2020 | |
| Geistlich Pharma, North America, INC. | $15.61 | 2021 | |
| Dentsply Sirona INC | $13.41 | 2019 | |
| Philips North America LLC | $13.00 | 2020 | |
| Henry Schein, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnau Aparicio-Altuna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.